Small Molecules
Excipients
Excipients Request for Revision Guideline: Substances other than the active pharmaceutical ingredient (API) that are intentionally included in an approved drug delivery system or a finished drug product.
Biologics
Path Forward and Stakeholder Engagement: Biologics Standards Development
Dietary Supplements, Herbal Medicines and Food Ingredient Guidelines
Botanical Dietary Supplements: Botanical drugs, botanical dietary supplements, and herbal medicine ingredients.
Non-Botanical Dietary Supplements: Vitamins, minerals, amino acids, and specialty ingredients (e.g., chondroitin, creatine, probiotics).
Admission of Dietary Supplement Ingredients to the USP–NF Monograph Development Process: Criteria used to determine whether a dietary ingredient qualifies for admission to the USP–NF process for quality monograph development.
Food Ingredients Monographs: Foods, food additives, food colors, processing aids (e.g., enzymes), and functional ingredients that affect the human body.
FCC Revisions
FCC Submission Checklist
Guideline for Assigning Titles to USP Dietary Supplement Monographs: This guideline streamlines the naming of dietary supplement (DS) monograph articles in the USP–NF and in the DSC. It provides a written systematic approach to developing monograph titles for dietary ingredients and dietary supplement dosage forms newly admitted to USP. In order to minimize the potential for confusion and controversy, the nomenclature approach is informed by the practices of the dietary supplement industry and the labeling requirements of applicable federal regulations.
Compounded Preparation Monograph
USP Compounding Monograph Donation Checklist
Additional Guidelines
USP Guideline on Use of Accelerated Processes for Revisions to the USP–NF: This guideline delineates the circumstances under which Errata, IRAs, and Revision Bulletins can be utilized to make revisions to the USP–NF official more quickly than through USP's standard revision process
USP Guideline on Drugs Approved for Inclusion: Under the Medicare program administered by the Centers for Medicare and Medicaid Services (CMS), certain drugs and biologics are eligible for reimbursement only upon being designated as “approved for inclusion” in the USP. This document includes background on the criteria for a product being “approved for inclusion” in the USP and provides manufacturers with guidelines on how to pursue the “approved for inclusion” designation for a newly approved product while a monograph is under development.
USP Guideline for Contributors of USP Reference Standard Candidate Materials: USP’s Reference Standard program relies on the generosity of partners, who, as experts in the field, provide high-quality candidate materials intended for use in the development of official public standards. This describes the general requirements for supplying such materials to USP.
